CALMODULIN CONTENT AND IN-VITRO CONTRACTILITY OF DUODENUM FROM STREPTOZOTOCIN-INDUCED DIABETIC RATS - EFFECTS OF INSULIN THERAPY AND CALMODULIN ANTAGONISM
Y. Ozturk et al., CALMODULIN CONTENT AND IN-VITRO CONTRACTILITY OF DUODENUM FROM STREPTOZOTOCIN-INDUCED DIABETIC RATS - EFFECTS OF INSULIN THERAPY AND CALMODULIN ANTAGONISM, European journal of pharmacology, 321(1), 1997, pp. 59-65
The effects of experimental diabetes and insulin treatment on the decr
eased reactivity of isolated rat duodenum to KCI and calmidazolium, a
specific calmodulin antagonist, were examined. After 8 weeks of strept
ozotocin diabetes, the contractile effect of KCI and the non-competiti
ve antagonistic effect of calmidazolium against KCI on isolated rat du
odenum were decreased. Calmodulin levels, as measured by radioimmunoas
say, were also found to be decreased in duodenum from streptozotocin-d
iabetic rats. Neither impaired reactivity to KCI nor decreased calmodu
lin levels in diabetic rat duodenum were corrected by treatment with i
nsulin (10 IU/kg for 20 days). Following insulin treatment, there was
only a partial correction in the antagonistic effect of calmidazolium
as shown by the increase in non-competitive antagonist affinity consta
nt.